New evidence has come out.
Red wine has often been thought to offer potential protection against cancer due to its high levels of resveratrol, an antioxidant with anti-inflammatory properties. However, a recent evidence review has found no solid proof that red wine lowers cancer risk. In fact, the study found no significant difference in overall cancer risk between red and white wine.
The study, published in the journal Nutrients, analyzed data from 42 studies involving nearly 96,000 participants. Researchers aimed to determine if red wine, because of its resveratrol content, was a healthier option compared to white wine. Surprisingly, the results revealed no meaningful difference in cancer risk between the two types of wine.
Resveratrol, while more concentrated in red wine, does not appear to offer much protection because the body metabolizes it quickly, with most of it being excreted. The study also identified some specific risks, including a 22% higher likelihood of skin cancer associated with white wine consumption compared to red wine.
White wine was also linked to an increased overall cancer risk in women. Researchers speculated that certain behaviors, such as indoor tanning or insufficient sunscreen use, could be contributing factors for the higher skin cancer risk tied to white wine consumption.
Overall, the study emphasizes that drinking red wine may not provide any significant advantage over white wine regarding cancer risk. It also highlights the harmful effects of alcohol, particularly the ethanol in alcoholic beverages, which can damage DNA and increase the likelihood of cancer.
Discussion about this post